1. Home
  2. MMS vs BCPC Comparison

MMS vs BCPC Comparison

Compare MMS & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMS
  • BCPC
  • Stock Information
  • Founded
  • MMS 1975
  • BCPC 1967
  • Country
  • MMS United States
  • BCPC United States
  • Employees
  • MMS N/A
  • BCPC N/A
  • Industry
  • MMS Business Services
  • BCPC Major Chemicals
  • Sector
  • MMS Consumer Discretionary
  • BCPC Industrials
  • Exchange
  • MMS Nasdaq
  • BCPC Nasdaq
  • Market Cap
  • MMS 4.8B
  • BCPC 4.6B
  • IPO Year
  • MMS 1997
  • BCPC N/A
  • Fundamental
  • Price
  • MMS $83.12
  • BCPC $153.39
  • Analyst Decision
  • MMS Buy
  • BCPC Strong Buy
  • Analyst Count
  • MMS 1
  • BCPC 1
  • Target Price
  • MMS $90.00
  • BCPC $190.00
  • AVG Volume (30 Days)
  • MMS 460.5K
  • BCPC 186.2K
  • Earning Date
  • MMS 11-20-2025
  • BCPC 10-21-2025
  • Dividend Yield
  • MMS 1.44%
  • BCPC 0.56%
  • EPS Growth
  • MMS 12.65
  • BCPC 22.48
  • EPS
  • MMS 5.37
  • BCPC 4.57
  • Revenue
  • MMS $5,428,731,000.00
  • BCPC $1,013,548,000.00
  • Revenue This Year
  • MMS $3.80
  • BCPC $9.58
  • Revenue Next Year
  • MMS $2.20
  • BCPC $6.32
  • P/E Ratio
  • MMS $15.48
  • BCPC $33.57
  • Revenue Growth
  • MMS 3.40
  • BCPC 7.55
  • 52 Week Low
  • MMS $63.77
  • BCPC $139.17
  • 52 Week High
  • MMS $93.73
  • BCPC $185.96
  • Technical
  • Relative Strength Index (RSI)
  • MMS 34.51
  • BCPC 52.98
  • Support Level
  • MMS $83.03
  • BCPC $151.85
  • Resistance Level
  • MMS $88.96
  • BCPC $156.28
  • Average True Range (ATR)
  • MMS 1.97
  • BCPC 3.69
  • MACD
  • MMS -0.45
  • BCPC 0.84
  • Stochastic Oscillator
  • MMS 30.27
  • BCPC 69.92

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Share on Social Networks: